الصفحة الرئيسية>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Acetyltransferases>>WM-1119

WM-1119

رقم الكتالوجGC18154

WM-1119 هو مثبط قوي للغاية وانتقائي KAT6A ، مع IC من 0.25 ميكرومتر لـ KAT6A في خلايا الليمفوما ، قيم KD الملزمة لـ WM-1119 مع KAT6A ، KAT5 و KAT7 هي 2 نانومتر ، 2.2 ميكرومتر ، 0.5 ميكرومتر ، على التوالي

Products are for research use only. Not for human use. We do not sell to patients.

WM-1119 التركيب الكيميائي

Cas No.: 2055397-28-7

الحجم السعر المخزون الكميّة
5mg
54٫00
متوفر
25mg
135٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Target: lysine acetyltransferases, KAT6A(MOZ), KAT6B(MORF/QKF)

WM-1119 induces cell cycle exit and cellular senescence without causing DNA damage. Senescence is INK4A/ARF-dependent and is accompanied by changes in gene expression that are typical of loss of KAT6A function. WM-1119, which has increased bioavailability, arrests the progression of lymphoma in mice

Data:

Treatment with WM-1119 arrests lymphoma growth.

Growth inhibition assays of Eμ-Myc lymphoma cell line EMRK1184 treated with WM-1119 and WM-8014 at the doses indicated.

WM-1119

KD(KAT6A)=0.002μM   KD(KAT5) = 2.2μM   KD(KAT7) = 0.5 μM

References      

1. Baell JB, et al. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. Nature. 2018 Aug;560(7717):253-257.

مراجعات

Review for WM-1119

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for WM-1119

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.